City of Hope Medical Center: Neoplasm Metastasis trials

The registry lists 18 Neoplasm Metastasis studies with City of Hope Medical Center as lead sponsor. 4 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 9Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid TumorsRecruitingNCT05733949Early Phase 1
• Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)RecruitingNCT05371132Phase 1
• Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic CancersRecruitingNCT05204147Phase 1
• PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingNCT04329494Phase 1
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTerminatedNCT01320683Phase 2Results posted
• Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadTerminatedNCT01159067Phase 2Results posted
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With SurgeryCompletedNCT00645710Phase 1/2Results posted
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerCompletedNCT00589563Phase 2Results posted
• STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWithdrawnNCT06626256Phase 1
• Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesSuspendedNCT06549478Phase 1
• Perception of Cure Among Patients With Metastatic CancerWithdrawnNCT04820894
• Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisWithdrawnNCT02528877Phase 1
• Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungWithdrawnNCT01741597Phase 1
• Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
• Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal DiseaseWithdrawnNCT01438021Not applicable
• Robotic-Assisted Surgery in Treating Patients With Spine TumorsWithdrawnNCT01345903Not applicable
• Minimally Invasive Surgery in Treating Patients With Spinal TumorsTerminatedNCT01308489Not applicable